Echinocandin: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 42: | Line 42: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Echinocandin_B.png|Echinocandin B structure | |||
File:Caspofungin.svg|Caspofungin structure | |||
File:Anidulafungin.svg|Anidulafungin structure | |||
</gallery> | |||
Latest revision as of 01:06, 18 February 2025
Echinocandin is a class of antifungal drugs that inhibit the synthesis of beta-glucan, a component of the fungal cell wall. They are typically used to treat invasive fungal infections in patients who are immunocompromised or critically ill.
Mechanism of Action[edit]
Echinocandins work by inhibiting the enzyme 1,3-beta-D-glucan synthase, which is responsible for the synthesis of beta-glucan. This leads to a weakening of the fungal cell wall and ultimately, cell death.
Types of Echinocandins[edit]
There are currently three echinocandins approved for use:
Each of these drugs has a slightly different spectrum of activity and side effect profile, but all are effective against a range of Candida species and Aspergillus species.
Side Effects[edit]
Common side effects of echinocandins include:
More serious side effects can include liver damage and anaphylaxis, although these are rare.
Drug Interactions[edit]
Echinocandins can interact with a number of other medications, including cyclosporine, tacrolimus, and sirolimus. These interactions can increase the risk of side effects and should be managed carefully.


